Nebulised ipratropium bromide in wheezy infants and young children.
D000281:Administration, Intranasal; D000367:Age Factors; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001286:Atropine Derivatives / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D009241:Ipratropium / Q000008:administration & dosage / Q000627:therapeutic use*; D010366:Peak Expiratory Flow Rate
D001286:Atropine Derivatives; D009241:Ipratropium; D000420:Albuterol